Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Prepaid Assets (2022 - 2025)

Axsome Therapeutics' Prepaid Assets history spans 4 years, with the latest figure at $13.7 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 13.97% year-over-year to $13.7 million; the TTM value through Dec 2025 reached $13.7 million, up 13.97%, while the annual FY2025 figure was $13.7 million, 13.97% up from the prior year.
  • Prepaid Assets for Q4 2025 was $13.7 million at Axsome Therapeutics, down from $19.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $19.8 million in Q3 2025 and bottomed at $2.1 million in Q1 2022.
  • The 4-year median for Prepaid Assets is $10.0 million (2023), against an average of $9.5 million.
  • The largest annual shift saw Prepaid Assets surged 191.8% in 2023 before it grew 13.97% in 2025.
  • A 4-year view of Prepaid Assets shows it stood at $2.8 million in 2022, then soared by 191.8% to $8.1 million in 2023, then skyrocketed by 47.6% to $12.0 million in 2024, then grew by 13.97% to $13.7 million in 2025.
  • Per Business Quant, the three most recent readings for AXSM's Prepaid Assets are $13.7 million (Q4 2025), $19.8 million (Q3 2025), and $16.3 million (Q2 2025).